Clinical Trial Update: Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD) [Phase 2]

View source ↗

Summary

Phase 2 trial update for Autologous Neo-Kidney Augment (NKA) in patients with Type 2 Diabetes and Chronic Kidney Disease; study terminated with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Autologous Neo-Kidney Augment

Snippet

Sponsor: Prokidney | Conditions: Chronic Kidney Disease, Type 2 Diabetes | Phase 2 | Status: TERMINATED | Results posted: 2021-04-23